Literature DB >> 33578944

Clinico-Pathological Importance of miR-146a in Lung Cancer.

Javaid Ahmad Wani1, Sabhiya Majid1, Andleeb Khan2, Azher Arafah3, Ajaz Ahmad3, Basit Latief Jan3, Naveed Nazir Shah4, Mohsin Kazi5, Muneeb U Rehman3.   

Abstract

Lung cancer is a well-known malignant tumor of the respiratory tract, which has caused a significant level of damage to human health in the 21st century. Micro-RNAs (miRNAs) are tiny, non-coding RNA stem-loop structures with a length of roughly 20-25 nucleotides that function as powerful modulators of mRNA and protein products of a gene. miRNAs may modulate many biological processes involving growth, differentiation, proliferation, and cell death and play a key role in the pathogenesis of various types of malignancies. Several accumulating pieces of evidence have proven that miRNA, especially miR-146a, are crucial modulators of innate immune response sequences. A novel and exciting cancer research field has involved miRNA for the detection and suppression of cancer. However, the actual mechanism which is adopted by these miRNA is still unclear. miRNAs have been used as a cancer-associated biomarker in several studies, suggesting their altered expression in various cancers compared to the normal cells. The amount of expression of miRNA can also be used to determine the stage of the disease, aiding in early detection. In breast, pancreatic, and hepatocellular carcinoma, and gastric cancer, cancer cell proliferation and metastasis has been suppressed by miR-146a. Changes in miR-146a expression levels have biomarker importance and possess a high potential as a therapeutic target in lung cancer. It retards epithelial-mesenchymal transition and promotes the therapeutic action of anticancer agents in lung cancer. Studies have also suggested that miR-146a affects gene expression through different signaling pathways viz. TNF-α, NF-κB and MEK-1/2, and JNK-1/2. Further research is required for understanding the molecular mechanisms of miR-146a in lung cancer. The potential role of miR-146a as a diagnostic marker of lung cancer must also be analyzed. This review summarizes the tumor-suppressing, anti-inflammatory, and antichemoresistive nature of miR-146a in lung cancer.

Entities:  

Keywords:  biomarker; clinical pathology; lung cancer; miR-146a

Year:  2021        PMID: 33578944      PMCID: PMC7916675          DOI: 10.3390/diagnostics11020274

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  124 in total

1.  Identification of small molecules that suppress microRNA function and reverse tumorigenesis.

Authors:  Koichi Watashi; Man Lung Yeung; Matthew F Starost; Ramachandra S Hosmane; Kuan-Teh Jeang
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

2.  Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection.

Authors:  Ana B Pavel; Joshua D Campbell; Gang Liu; David Elashoff; Steven Dubinett; Kate Smith; Duncan Whitney; Marc E Lenburg; Avrum Spira
Journal:  Cancer Prev Res (Phila)       Date:  2017-09-06

3.  Tumor Necrosis Factor-Induced miR-146a Upregulation Promotes Human Lung Adenocarcinoma Metastasis by Targeting Merlin.

Authors:  Nilda C Sánchez; Elisa Medrano-Jiménez; Diana Aguilar-León; Leonor Pérez-Martínez; Gustavo Pedraza-Alva
Journal:  DNA Cell Biol       Date:  2020-01-30       Impact factor: 3.311

Review 4.  Epidermal growth factor receptor mutations in lung cancer.

Authors:  Sreenath V Sharma; Daphne W Bell; Jeffrey Settleman; Daniel A Haber
Journal:  Nat Rev Cancer       Date:  2007-03       Impact factor: 60.716

5.  MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8.

Authors:  Dipa Bhaumik; Gary K Scott; Shiruyeh Schokrpur; Christopher K Patil; Arturo V Orjalo; Francis Rodier; Gordon J Lithgow; Judith Campisi
Journal:  Aging (Albany NY)       Date:  2009-04       Impact factor: 5.682

Review 6.  A collective route to metastasis: Seeding by tumor cell clusters.

Authors:  Kevin J Cheung; Andrew J Ewald
Journal:  Science       Date:  2016-04-08       Impact factor: 47.728

7.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

8.  MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.

Authors:  D-L Yuwen; B-B Sheng; J Liu; W Wenyu; Y-Q Shu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-06       Impact factor: 3.507

9.  Inhibition of microRNA function by antimiR oligonucleotides.

Authors:  Jan Stenvang; Andreas Petri; Morten Lindow; Susanna Obad; Sakari Kauppinen
Journal:  Silence       Date:  2012-01-09

10.  miR‑146a‑5p targets TCSF and influences cell growth and apoptosis to repress NSCLC progression.

Authors:  Wen-Ting Huang; Rong-Quan He; Xiao-Jiao Li; Jie Ma; Zhi-Gang Peng; Jin-Cai Zhong; Xiao-Hua Hu; Gang Chen
Journal:  Oncol Rep       Date:  2019-02-25       Impact factor: 3.906

View more
  9 in total

Review 1.  Clinical Implications of Circulating Circular RNAs in Lung Cancer.

Authors:  Sae Seul Choi; Sae Eun Kim; Seon Young Oh; Young-Ho Ahn
Journal:  Biomedicines       Date:  2022-04-08

Review 2.  Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands.

Authors:  Sarah Sayed Hassanein; Sherif Abdelaziz Ibrahim; Ahmed Lotfy Abdel-Mawgood
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

3.  Efficacy of High-Ozonide Oil in Prevention of Cancer Relapses Mechanisms and Clinical Evidence.

Authors:  Alberto Izzotti; Enzo Fracchia; Camillo Rosano; Antonio Comite; Liliana Belgioia; Salvatore Sciacca; Zumama Khalid; Matteo Congiu; Cristina Colarossi; Giusi Blanco; Antonio Santoro; Massimo Chiara; Alessandra Pulliero
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.639

Review 4.  MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential.

Authors:  Javaid Ahmad Wani; Sabhiya Majid; Zuha Imtiyaz; Muneeb U Rehman; Rana M Alsaffar; Naveed Nazir Shah; Sultan Alshehri; Mohammed M Ghoneim; Syed Sarim Imam
Journal:  Diagnostics (Basel)       Date:  2022-07-01

5.  Electroacupuncture-Regulated miR-34a-3p/PDCD6 Axis Promotes Post-Spinal Cord Injury Recovery in Both In Vitro and In Vivo Settings.

Authors:  Lili Ma; Lizhong Ma; Yu Yang; Ting Chen; Limin Wang; Qilong Deng
Journal:  J Immunol Res       Date:  2022-09-12       Impact factor: 4.493

6.  A Comprehensive Cancer-Associated MicroRNA Expression Profiling and Proteomic Analysis of Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes.

Authors:  Ganesan Jothimani; Surajit Pathak; Suman Dutta; Asim K Duttaroy; Antara Banerjee
Journal:  Tissue Eng Regen Med       Date:  2022-05-05       Impact factor: 4.451

Review 7.  Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.

Authors:  Arsinoe C Thomaidou; Panagiota Batsaki; Maria Adamaki; Maria Goulielmaki; Constantin N Baxevanis; Vassilis Zoumpourlis; Sotirios P Fortis
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

Review 8.  The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer.

Authors:  Michał Szczyrek; Paulina Bitkowska; Marta Jutrzenka; Janusz Milanowski
Journal:  J Pers Med       Date:  2022-07-27

Review 9.  Pleiotropic effects of DCLK1 in cancer and cancer stem cells.

Authors:  Dibyashree Chhetri; Srinivasan Vengadassalapathy; Santhosh Venkadassalapathy; Varadharaju Balachandran; Vidhya Rekha Umapathy; Vishnu Priya Veeraraghavan; Selvaraj Jayaraman; Shankargouda Patil; Ashok Iyaswamy; Kanagaraj Palaniyandi; Dhanavathy Gnanasampanthapandian
Journal:  Front Mol Biosci       Date:  2022-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.